Through passive transfer of an HBV core antigen specific mAb, we further demonstrated that the anti-HBc IgG administered at the acute phase of AAV8-1.3HBV infection could suppress the increase of circulating HBsAg in mice. The gene discussed is KRT88P; the disease is infection.